Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mutlay Sayan

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
European Urology Oncology|May 30, 2025
Impact of Prostate Radiotherapy on Survival Outcomes in Patients with Metastatic Castration-sensitive Prostate Cancer: A Meta-analysis of Randomized Phase 3 Clinical TrialsSatı Coşkun Yazgan, Emre Yekedüz, Mutlay Sayan, et al.
Frontiers in Oncology|January 27, 2017
Development of Late Toxicities in Patients with Oral Tongue Cancer Treated with Surgical Resection and Adjuvant Radiation TherapyMutlay Sayan, Richard J Cassidy, Jeffrey M Switchenko, et al.
Advances in Respiratory Medicine|November 5, 2019
Current treatment strategies in malignant pleural mesothelioma with a treatment algorithmMutlay Sayan, Mehmet Fuat Eren, Apar Gupta, et al.
International Journal of Surgical Pathology|March 13, 2026
Prediction of Specific Survival and Clinicopathological Impact of Somatic PALB2 Mutations and Pathogenic/Likely Pathogenic Variants (PV/LPV) in Breast Cancer: A Cohort Study of 81 PatientsYousef M Hamsawi, Ibrahim Mansoor, Mutlay Sayan, et al.
Particle and Fibre Toxicology|August 14, 2013
Asbestos and erionite prime and activate the NLRP3 inflammasome that stimulates autocrine cytokine release in human mesothelial cellsJedd M Hillegass, Jill M Miller, Maximilian B MacPherson, et al.
Practical Radiation Oncology|April 24, 2025
Combination Metastasis-Targeted External Beam Radiation Therapy With <sup>177</sup>Lu-PSMA-617 in Patients With Advanced Castration-Resistant Prostate CancerSedra Mohammadi, Isabella R Pompa, Veronica Haberman, et al.
BMC Urology|February 9, 2024
Prostate cancer presentation and management in the Middle EastMutlay Sayan, Astrid Langoe, Ozlem Aynaci, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|June 23, 2012
A multifunctional mesothelin antibody-tagged microparticle targets human mesotheliomasSherrill L Macura, Jedd M Hillegass, Jeremy L Steinbacher, et al.
BMC Cancer|September 13, 2013
Microspheres targeted with a mesothelin antibody and loaded with doxorubicin reduce tumor volume of human mesotheliomas in xenograftsSherrill L Macura, Jeremy L Steinbacher, Maximilian B Macpherson, et al.
JCO Global Oncology|July 11, 2024
Prostate Cancer Awareness in the Middle East: A Cross-Sectional International StudyMutlay Sayan, Ayfer Ay Eren, Yetkin Tuac, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
European Urology Oncology|May 30, 2025
Impact of Prostate Radiotherapy on Survival Outcomes in Patients with Metastatic Castration-sensitive Prostate Cancer: A Meta-analysis of Randomized Phase 3 Clinical TrialsSatı Coşkun Yazgan, Emre Yekedüz, Mutlay Sayan, et al.
Frontiers in Oncology|January 27, 2017
Development of Late Toxicities in Patients with Oral Tongue Cancer Treated with Surgical Resection and Adjuvant Radiation TherapyMutlay Sayan, Richard J Cassidy, Jeffrey M Switchenko, et al.
Advances in Respiratory Medicine|November 5, 2019
Current treatment strategies in malignant pleural mesothelioma with a treatment algorithmMutlay Sayan, Mehmet Fuat Eren, Apar Gupta, et al.
International Journal of Surgical Pathology|March 13, 2026
Prediction of Specific Survival and Clinicopathological Impact of Somatic PALB2 Mutations and Pathogenic/Likely Pathogenic Variants (PV/LPV) in Breast Cancer: A Cohort Study of 81 PatientsYousef M Hamsawi, Ibrahim Mansoor, Mutlay Sayan, et al.
Particle and Fibre Toxicology|August 14, 2013
Asbestos and erionite prime and activate the NLRP3 inflammasome that stimulates autocrine cytokine release in human mesothelial cellsJedd M Hillegass, Jill M Miller, Maximilian B MacPherson, et al.
Practical Radiation Oncology|April 24, 2025
Combination Metastasis-Targeted External Beam Radiation Therapy With <sup>177</sup>Lu-PSMA-617 in Patients With Advanced Castration-Resistant Prostate CancerSedra Mohammadi, Isabella R Pompa, Veronica Haberman, et al.
BMC Urology|February 9, 2024
Prostate cancer presentation and management in the Middle EastMutlay Sayan, Astrid Langoe, Ozlem Aynaci, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|June 23, 2012
A multifunctional mesothelin antibody-tagged microparticle targets human mesotheliomasSherrill L Macura, Jedd M Hillegass, Jeremy L Steinbacher, et al.
BMC Cancer|September 13, 2013
Microspheres targeted with a mesothelin antibody and loaded with doxorubicin reduce tumor volume of human mesotheliomas in xenograftsSherrill L Macura, Jeremy L Steinbacher, Maximilian B Macpherson, et al.
JCO Global Oncology|July 11, 2024
Prostate Cancer Awareness in the Middle East: A Cross-Sectional International StudyMutlay Sayan, Ayfer Ay Eren, Yetkin Tuac, et al.
Pageof 10